These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 17325553

  • 1. Effect of antireflux treatment on asthma exacerbations in nonatopic children.
    Khoshoo V, Haydel R.
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):331-5. PubMed ID: 17325553
    [Abstract] [Full Text] [Related]

  • 2. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
    Sontag SJ, O'Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G, Miller T, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
    [Abstract] [Full Text] [Related]

  • 3. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 4. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.
    Norman Hansen A, Bergheim R, Fagertun H, Lund H, Moum B.
    Int J Clin Pract; 2005 Jun; 59(6):665-71. PubMed ID: 15924594
    [Abstract] [Full Text] [Related]

  • 5. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
    Maev IV, Viuchnova ES, Balashova NN, Shchekina MI.
    Eksp Klin Gastroenterol; 2003 Jun; (3):26-31, 116. PubMed ID: 14556543
    [Abstract] [Full Text] [Related]

  • 6. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [Abstract] [Full Text] [Related]

  • 7. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H, Yilmaz O, Kirmaz C, Aydoğdu S, Kasirga E.
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [Abstract] [Full Text] [Related]

  • 8. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.
    Rantanen TK, Sihvo EI, Räsänen JV, Salo JA.
    Am J Gastroenterol; 2007 Feb; 102(2):246-53. PubMed ID: 17156140
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of antireflux therapy in asthmatic children with gastroesophageal reflux disease].
    Farcău D, Dreghiciu D, Cherecheş-Panţa P, Popa M, Farcău M, Nanulescu M.
    Pneumologia; 2004 Feb; 53(4):207-11. PubMed ID: 16106733
    [Abstract] [Full Text] [Related]

  • 10. Gastroesophageal reflux disease: new treatments.
    Katz PO.
    Rev Gastroenterol Disord; 2002 Feb; 2(2):66-74. PubMed ID: 12122962
    [Abstract] [Full Text] [Related]

  • 11. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.
    Kiljander T, Rantanen T, Kellokumpu I, Kööbi T, Lammi L, Nieminen M, Poussa T, Ranta A, Saarelainen S, Salminen P.
    Clin Respir J; 2013 Jul; 7(3):281-7. PubMed ID: 23006321
    [Abstract] [Full Text] [Related]

  • 13. [GERD (gastroesophageal reflux disease)].
    Dobashi K.
    Nihon Rinsho; 2001 Oct; 59(10):2045-50. PubMed ID: 11676152
    [Abstract] [Full Text] [Related]

  • 14. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [Abstract] [Full Text] [Related]

  • 15. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
    Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ.
    Am J Gastroenterol; 2010 Nov; 105(11):2341-6. PubMed ID: 20842110
    [Abstract] [Full Text] [Related]

  • 16. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
    Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
    [Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.
    Gilger MA, Tolia V, Vandenplas Y, Youssef NN, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):524-33. PubMed ID: 18493207
    [Abstract] [Full Text] [Related]

  • 18. Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting.
    Hansen AN, Bergheim R, Fagertun H, Lund H, Wiklund I, Moum B.
    Int J Clin Pract; 2006 Jan; 60(1):15-22. PubMed ID: 16409423
    [Abstract] [Full Text] [Related]

  • 19. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.
    Hansen AN, Wahlqvist P, Jørgensen E, Bergheim R, Fagertun H, Lund H, Moum B.
    Int J Clin Pract; 2005 Jun; 59(6):655-64. PubMed ID: 15924593
    [Abstract] [Full Text] [Related]

  • 20. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment.
    Khoshoo V, Mohnot S, Haydel R, Saturno E, Edell D, Kobernick A.
    Pediatr Pulmonol; 2009 Nov; 44(11):1070-4. PubMed ID: 19830719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.